Discover
EWTX
Edgewise Therapeutics, Inc.
39.15
2 x 29.16
2 x 50.27
bid
ask
-
1.48
3.64%
2 @ 05:03 AM
39.60 +0.45 (1.15%)
| Ytd | 57.74% | |
| 1y | 205.38% |
38.77
day range
41.08
12.30
52 week range
43.93
| Open | 40.32 | Prev Close | 40.63 | Low | 38.77 | High | 41.08 | Mkt Cap | 4.21B |
| Vol | 1.22M | Avg Vol | 1.41M | EPS | -1.66 | P/E | N/A | Forward P/E | -27.48 |
| Beta | 0.30 | Short Ratio | 7.08 | Inst. Own | 113.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 34.86 | 200-d Avg | 27.01 | 1yr Est | 48.17 |
| Income Statement | |||
| Operating Expenses | 54.12M | ||
| Research and Development Expense | 42.65M | ||
| Selling, General and Administrative Expense | 11.46M | ||
| Operating Income | -54.11M | ||
| Net Income | -49.01M | ||
| Net Income Common Stock | -49.01M | ||
| Net Income Common Stock (USD) | -49.01M | ||
| Consolidated Income | -49.01M | ||
| Earnings per Basic Share | -0.46 | ||
| Earnings per Basic Share (USD) | -0.46 | ||
| Earnings per Diluted Share | -0.46 | ||
| Earning Before Interest & Taxes (EBIT) | -49.01M | ||
| Earning Before Interest & Taxes (USD) | -49.01M | ||
| Weighted Average Shares | 107.12M | ||
| Weighted Average Shares Diluted | 107.12M | ||
| Balance Sheet | |||
| Cash and Equivalents | 33.21M | ||
| Cash and Equivalents (USD) | 33.21M | ||
| Investments | 466.35M | ||
| Investments Current | 466.35M | ||
| Current Assets | 509.79M | ||
| Property, Plant & Equipment Net | 8.73M | ||
| Total Assets | 518.52M | ||
| Debt Current | 1.02M | ||
| Total Debt | 3.79M | ||
| Current Liabilities | 22.54M | ||
| Debt Non-Current | 2.78M | ||
| Total Liabilities | 25.32M | ||
| Accumulated Retained Earnings (Deficit) | -595.38M | ||
| Accumulated Other Comprehensive Income | -252.00K | ||
| Shareholders Equity | 493.20M | ||
| Shareholders Equity (USD) | 493.20M | ||
| Assets Non-Current | 8.73M | ||
| Total Debt (USD) | 3.79M | ||
| Liabilities Non-Current | 2.78M | ||
| Trade and Non-Trade Payables | 7.29M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 590.00K | ||
| Net Cash Flow from Financing | 12.17M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -27.94M | ||
| Capital Expenditure | -260.00K | ||
| Issuance (Purchase) of Equity Shares | 12.17M | ||
| Net Cash Flow from Investing | 2.43M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.69M | ||
| Net Cash Flow from Operations | -42.54M | ||
| Share Based Compensation | 8.72M | ||